Adverse Outcomes of Assisted Reproductive Technologies (P01)

The summary for the Adverse Outcomes of Assisted Reproductive Technologies (P01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Adverse Outcomes of Assisted Reproductive Technologies (P01): Purpose. This Funding Opportunity Announcement (FOA), issued by the National Institute of Child Health and Human Development (NICHD), encourages Program Project Grant (P01) applications from institutions/organizations that propose to study the ways in which Assisted Reproductive Technologies (ART) may affect eggs, sperm and preimplantation embryos that could, in turn, lead to adverse outcomes during fetal development, the perinatal period, childhood, adulthood or even subsequent generations. While most ART offspring appear to be healthy and developing normally, there are some reports of adverse outcomes and some concerns owing to the variety and type of ART protocols in use. This FOA encourages applications on human subjects and animal models that can include a wide variety of basic, clinical and epidemiological approaches. P01 applicants can take advantage of this FOA to propose multidisciplinary, interactive and synergistic program projects in order to address some of these issues. It is anticipated that this FOA will provide empirical data for understanding ART outcomes and also how reproductive health is fundamental to overall health and quality of life.

Federal Grant Title:	Adverse Outcomes of Assisted Reproductive Technologies (P01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-08-103
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	May 07, 2011
Posted Date:	Mar 06, 2008
Creation Date:	Dec 03, 2008
Archive Date:	Dec 04, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Private institutions of higher education Special district governments Public and State controlled institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Public housing authorities/Indian housing authorities For profit organizations other than small businesses Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments County governments
Additional Information on Eligibility: Foreign institutions are eligible to apply.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical...; • Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial No...; • Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P5...; • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...; • Early Immune System Development and Ontogeny (R01 Clinical Trial Optional); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed); • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional); • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...; • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...; • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Re...